Dark

ATHE
Alterity Therapeutics Limited
stock NASDAQ ADR

At Close

Jul 30, 2026 11:37:54 AM EDT

4.32USD-2.703%(-0.12)9,532

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-4.44)0

After-hours

Jul 29, 2026 4:50:30 PM EDT

4.42USD0.000%(+4.42)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

80.30M

Headquarters

Melbourne, Victoria, Australia

Industry

Biotechnology

Next Earnings

Aug 27, 2026 (27d)

Last Split

Jan 9, 20231for10reverse

ATHE Stats

Avg. Vol. 10 Day

11,336

Avg. Vol. 30 Day

20,132

Employees

Market Cap

80,296,824

Shares Out.

18,125,694

On/Off Exchange

48%/52%

6 Month Beta

0.85

1 Year Beta

1.37

2 Year Beta

0.61

3 Year Beta

0.34

52 Week Low

2.66

52 Week High

5.89

SMA50

4.67

SMA200

3.96

1 Week

-2.42%

1 Month

-18.86%

3 Month

-6.24%

6 Month

+39.75%

1 Year

-12.45%

2 Year

+176.89%

5 Year

-65.66%

Profile

alterity therapeutics limited researches and develops therapeutic drugs for the treatment of parkinsonian's disease and other neurodegenerative diseases in australia. the company's lead drug candidates is ath434 that has completed phase i clinical trial for the treatment of parkinson's disease. it is also developing pbt2 for used as an antimicrobial agent. the company was formerly known as prana biotechnology limited and changed its name to alterity therapeutics limited in april 2019. the company was founded in 1997 and is based in melbourne, australia.

ATHE Stock Summary

Alterity Therapeutics Limited (NASDAQ:ATHE) stock price today is $4.32, and today's volume is 9,532. ATHE is down -2.703% today. The 30 day average volume is 20,132. ATHE market cap is 80.30M with 18,125,694 shares outstanding.

.dark-mode .bKrq65{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .bKrq65{ color: #333333; background-color: white; border: 2px solid #333333; }ATHEAlterity Therapeutics Limitedstock NASDAQ ADR

ATHE Stock Summary

ATHE
Alterity Therapeutics Limited
stock NASDAQ ADR